These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Sartor RB Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232 [TBL] [Abstract][Full Text] [Related]
4. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. Hibi T; Inoue N; Ogata H; Naganuma M J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869 [TBL] [Abstract][Full Text] [Related]
5. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America. ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel diseases: controversies in the use of diagnostic procedures. Vucelic B Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751 [TBL] [Abstract][Full Text] [Related]
7. [Current developments in the diagnosis and therapy of Crohn disease and ulcerative colitis]. Hammer B Schweiz Med Wochenschr; 1994 Mar; 124(11):452-60. PubMed ID: 8146628 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory bowel disease. An epidemiological and genetic study. Monsén U Acta Chir Scand Suppl; 1990; 559():1-42. PubMed ID: 2092567 [TBL] [Abstract][Full Text] [Related]
9. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787 [TBL] [Abstract][Full Text] [Related]
10. Medical management of patients with difficult-to-treat inflammatory bowel disease. van Hogezand RA Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006 [TBL] [Abstract][Full Text] [Related]
11. Management of inflammatory bowel disease. Botoman VA; Bonner GF; Botoman DA Am Fam Physician; 1998 Jan; 57(1):57-68, 71-2. PubMed ID: 9447214 [TBL] [Abstract][Full Text] [Related]
12. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
17. [Standards, perspectives and limits of conservative therapy of chronic inflammatory bowel diseases]. Rogler G; Andus T; Schölmerich J Zentralbl Chir; 1998; 123(4):316-24. PubMed ID: 9622888 [TBL] [Abstract][Full Text] [Related]
18. The state of the art in the management of inflammatory bowel disease. Hanauer SB; Present DH Rev Gastroenterol Disord; 2003; 3(2):81-92. PubMed ID: 12776005 [TBL] [Abstract][Full Text] [Related]